Prof. Roger Schibli, Head of the Center for Radiopharmaceutical Science at PSI Paul Scherrer Institute…
SHANGHAI, China, April 27, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”,…
Seven patients with cHBV remain off all treatment and continue to maintain low levels of…
LoRaWAN® Industry 5.0 LoRaWAN® drives Industry 5.0’s sustainability, efficiency, and quality of life priorities globally….
Harnessing the transformative power of generative AI for modern workplaces with integrations for ChatGPT, Google…
The Marketing Delivery platform eliminates the inefficiency, inaccuracy, and chaos of managing digital assets and…
STAMFORD, Conn.–(BUSINESS WIRE)–United Rentals, Inc. (NYSE: URI) today announced financial results for the first quarter…
NEW YORK–(BUSINESS WIRE)–Griffon Corporation (“Griffon” or the “Company”) (NYSE: GFF) today announced it will release…
Net sales of $574 million, a decrease of 16% from the first quarter last year…
NEW YORK–(BUSINESS WIRE)–Annaly Capital Management, Inc. (NYSE: NLY) (“Annaly” or the “Company”) today announced its…
Rotkreuz, Switzerland: 27/04/23. The Infinigate Group, the value-add distributor of cybersecurity, secure networks and secure…
Fareham, UK: 27/04/23. Vuzion, an Infinigate Group company, is rebranding to Infinigate Cloud, fulfilling the…
BERKELEY, Calif. and MAINZ, Germany, April 27, 2023 (GLOBE NEWSWIRE) — Mainz Biomed NV (NASDAQ:MYNZ)…
BERKELEY, Calif. and MAINZ, Germany, April 27, 2023 (GLOBE NEWSWIRE) — Mainz Biomed NV (NASDAQ:MYNZ)…
PRESS RELEASE Sartorius and va-Q-tec announce a long-term partnership for the joint development of innovative…
PRESS RELEASE Sartorius and va-Q-tec announce a long-term partnership for the joint development of innovative…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
Oslo, Norway, 27th of April 2023 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces…
Strong Q1 growth driven by Specialty Care, Vaccines and CHC Paris, April 27, 2023 Q1…